Decoding the GPO Maze: Unlocking Medtech Market Access and Investor Returns
Webinar Overview
Group Purchasing Organizations (GPOs) play a major role in determining which medical technologies gain traction in hospitals and health systems, yet their influence is often misunderstood or overlooked.
In this session, Paul Slosar (Co-Founder and Partner, Physicians Capital Fund) will moderate a conversation with Chris Stewart (VP, Med Device Management, HealthTrust ) on how GPOs evaluate new technologies, what drives contracting decisions, and how startups engage with them. The discussion will offer practical insight for anyone interested in how healthcare innovation moves from concept to clinical adoption.
Why Attend
Get a clearer understanding of how GPOs shape medtech adoption
Learn what GPOs look for when reviewing new medical technologies
Gain perspective on a key factor that influences go-to-market strategy in healthcare
This session will be recorded. If you can't make it live, RSVP anyway to receive the recording.
About the Speakers
Chris Stewart has 20 years of healthcare leadership experience in medical device PPI management, value-based initiatives, technology development, supply chain transformation, and digital acceleration. Previously, Chris was President and CEO of Surgio Health, a startup venture focused on the digital tracking of surgical assets in the OR and the sterile processing department. He also co-founded a relational mapping technology called MedTechIntel that has over 100,000 physician profiles, and has years of experience in sales and sales management for Stryker.
Paul Slosar, MD, MHCDS is an orthopedic spine surgeon who practiced for 28 years, including 13 years as president and administrative partner, in the San Francisco Bay area. Dr. Slosar also has extensive experience as a Health Tech operator and advisor with multiple successful exits. He currently works full-time as a med-tech executive and strategic consultant for healthcare companies. Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Certificate in Value-Based Health Care from Harvard Business School.